ArticleBMJ public health2026
Insights into public use and attitudes of cannabidiol (CBD) in England, Wales and Northern Ireland: secondary analysis of an official statistic consumer survey, Food and You 2.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cannabidiol (CBD) is a naturally occurring phytocannabinoid found in Methods: The current research analysed data from the Official Statistics survey, Food and You 2 (n=13 879), Wave 1 (2020), Wave 3 (2021) and Wave 7 (2023). A series of binary logistic regression models were used to identify the characteristics associated with CBD awareness and use. Cluster analyses examined CBD product usage and how consumers decide on a suitable dose/serving. Results: It was identified that 61.9% of respondents had heard of CBD, and of those who had heard of CBD, 17.1% had used CBD in the previous 12 months. The characteristics associated with CBD awareness and use are not uniform. How CBD users decide on a suitable dose/serving varies, with some using a combination of methods, others relying on pack instructions alone or not thinking about this issue. Conclusions: This research offers novel insight into the awareness and use of CBD products across England, Wales and Northern Ireland, providing an evidence base for policymakers to better understand and monitor CBD awareness and use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.